Efficient execution capabilities and strengths
Launch 6 PoC studies within 2 years
Flexible corporate structure
To enable global partnership in the field of cell and gene therapies
Strong technology platforms and cellular immunotherapies
Seasoned team with rich experience to conduct PD/AD, manufacturing and quality specification,regulation,and clinical development
Clinical source
Strong alliance with top tier hospitals (18 Class 3A hospitals, total50,000 beds)
Manufacturing facility
Global standards of cell gene therapy manufacturing(compliance with EMA and FDA)
Sophisticated investors,continuous and long-term investment
Governmental trend
Continuous support to fuel biotech innovations
Please contact us
T : +86 136 8187 0758
M : Linc.he@gracellbio.com